President Biden (Patrick Semansky/AP Images)

US gov­ern­ment pledges $2B for new ini­tia­tive on bio­man­u­fac­tur­ing

Over the past few days, the Biden ad­min­is­tra­tion has been fo­cused on new sci­ence ef­forts, par­tic­u­lar­ly around can­cer, and grow­ing bio­man­u­fac­tur­ing in the US.

On Wednes­day, the White House held a sum­mit on biotech and bio­man­u­fac­tur­ing, re­veal­ing what it will spend to boost these ef­forts.

Bri­an Deese, di­rec­tor of the Na­tion­al Eco­nom­ic Coun­cil, said that the ad­min­is­tra­tion has been fo­cused on a mod­ern in­dus­tri­al strat­e­gy by plac­ing pub­lic funds in ef­forts that in­vest in in­fra­struc­ture and se­cure sup­ply chains. He al­so said that the fo­cus of the ini­tia­tive is to in­crease the do­mes­tic man­u­fac­tur­ing of APIs to lim­it the de­pen­dence on for­eign sup­pli­ers as well as in­crease the do­mes­tic man­u­fac­tur­ing ca­pac­i­ty in gen­er­al and cre­ate jobs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.